CHIRALITY EMERGES AS KEY ISSUE IN PHARMACEUTICAL RESEARCH

[1] CARTER JE, 1988, DRUG STEREOCHEMISTRY

[2] THE FDA PERSPECTIVE ON THE DEVELOPMENT OF STEREOISOMERS [J]. CHIRALITY, 1989, 1 (01) : 2 - 6

[3] CHIRAL METAL-COMPLEXES AS DISCRIMINATING MOLECULAR CATALYSTS [J]. SCIENCE, 1990, 248 (4960) : 1194 - 1199

[4] SHELDON, 1990, CHEM IND, V7, P212

[5] 1990, PHARMACEUT RES, V7, P683

[6] 1990, PHARM TECHNOLOGY MAY, P46

[1] CARTER JE, 1988, DRUG STEREOCHEMISTRY

[2] THE FDA PERSPECTIVE ON THE DEVELOPMENT OF STEREOISOMERS [J]. CHIRALITY, 1989, 1 (01) : 2 - 6

[3] CHIRAL METAL-COMPLEXES AS DISCRIMINATING MOLECULAR CATALYSTS [J]. SCIENCE, 1990, 248 (4960) : 1194 - 1199

[4] SHELDON, 1990, CHEM IND, V7, P212

[5] 1990, PHARMACEUT RES, V7, P683

[6] 1990, PHARM TECHNOLOGY MAY, P46